Literature DB >> 33241208

Ewing Sarcoma With Emphasis on Extra-skeletal Ewing Sarcoma: A Decade's Experience From a Single Centre in India.

Sudha S Murthy1, S Challa1, Kvvn Raju2, S J Rajappa3, D Fonseca1, S D Gundimeda1, B V Rao1, F Ahmed1, S Kodandapani1, L Nambaru1, M C Mundada1, R Sharma2, K M Mallavarapu3, V C Koppula4, T S Rao4.   

Abstract

INTRODUCTION: The diagnosis of Ewing sarcoma family of tumours (ESFT) is challenging, especially in adults and in extra-skeletal or visceral location. Several morphologic mimics with varied treatment options and prognosis confer diagnostic dilemmas. Application of ancillary diagnostic modalities in surgical pathology in clinical routine has enabled accurate diagnosis of ESFT in bone, soft tissues, and viscera. AIM: The study aims to assess the clinicopathological features including molecular test results of ESFT with emphasis on sex, age, and location, especially extra-skeletal soft tissue and visceral location.
MATERIAL AND METHODS: Data of clinicopathological, molecular tests (wherever performed), diagnosis rendered in 302 ESFT over a decade from our centre were reviewed. Statistical comparison of skeletal and extra-skeletal tumours with reference to age and sex was done using SPSS package. The P value of <.05 was considered significant.
RESULTS: The cohort included 302 ESFTs with 49% skeletal and 51% extra-skeletal tumours. Thigh was most common site among skeletal tumours; chest wall, paraspinal location, and retroperitoneum among soft tissues (39.4%); and kidney, ovary, and cervix among visceral tumours (11.3%). Fluorescence in situ hybridisation for EWSR1 gene rearrangement was positive in 54 patients and reverse-transcriptase polymerase chain reaction in 19 patients. Predominance of male sex, younger age and location in extremities among skeletal tumours and lack of gender predilection, higher age and axial location in extra-skeletal tumours were noted, which were statistically significant. Molecular tests were performed more frequently in extra-skeletal tumours, especially in visceral tumours to establish the diagnosis.
CONCLUSIONS: The study showed statistically significant differences in the age, sex, and location between skeletal and extra-skeletal ESFT. The increased percentage of extra-skeletal tumours especially in viscera was attributed to the increased awareness and availability of ancillary techniques.
© The Author(s) 2020.

Entities:  

Keywords:  Ewing sarcoma family of tumours; extra-skeletal; fluorescence in situ hybridisation; reverse-transcriptase polymerase chain reaction; skeletal; visceral

Year:  2020        PMID: 33241208      PMCID: PMC7672761          DOI: 10.1177/2632010X20970210

Source DB:  PubMed          Journal:  Clin Pathol        ISSN: 2632-010X


  57 in total

1.  Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P G Casali; J-Y Blay
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Involvement of Mediastinal Lymph Nodes by Ewing's Sarcoma.

Authors:  Alberto Caballero Vázquez; Paula García Flores; Ángela Herrera Chilla
Journal:  Arch Bronconeumol       Date:  2016-10-15       Impact factor: 4.872

3.  Primary primitive neuroectodermal tumor of the ovary.

Authors:  Ling-Hui Chu; Wen-Chun Chang; Kuan-Ting Kuo; Bor-Ching Sheu
Journal:  Taiwan J Obstet Gynecol       Date:  2014-09       Impact factor: 1.705

4.  Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.

Authors:  Mark A Applebaum; Jennifer Worch; Katherine K Matthay; Robert Goldsby; John Neuhaus; Daniel C West; Steven G Dubois
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

5.  Visceral primitive peripheral neuroectodermal tumors: a clinicopathologic and molecular study.

Authors:  M J O'Sullivan; E J Perlman; J Furman; P A Humphrey; L P Dehner; J D Pfeifer
Journal:  Hum Pathol       Date:  2001-10       Impact factor: 3.466

6.  Extraskeletal Ewing Sarcoma of the Jejunum: A Case Report.

Authors:  Colby Cantu; Elizabeth Bressler; Josephine Dermawan; Kristen Paral
Journal:  Perm J       Date:  2019-06-07

7.  Primitive neuroectodermal tumor/Ewing's sarcoma of the urinary bladder: a case report and its molecular diagnosis.

Authors:  Yohei Okada; Shigeyoshi Kamata; Takumi Akashi; Morihito Kurata; Takuro Nakamura; Kazunori Kihara
Journal:  Int J Clin Oncol       Date:  2010-11-10       Impact factor: 3.402

8.  Primary vaginal Ewing's sarcoma or primitive neuroectodermal tumor in a 17-year-old woman: a case report.

Authors:  Bharat Rekhi; Sajid Qureshi; Ranjan Basak; Sangeeta B Desai; Seema Medhi; Purna Kurkure; Santosh Menon; Amita Maheshwari; Nirmala A Jambhekar
Journal:  J Med Case Rep       Date:  2010-03-17

9.  Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour.

Authors:  Alfredo Pinto; Paul Dickman; David Parham
Journal:  Sarcoma       Date:  2010-10-14

10.  Primitive neuroectodermal tumor/Ewing's sarcoma in adult uro-oncology: A case series from a developing country.

Authors:  Rehan Mohsin; Altaf Hashmi; Muhammed Mubarak; Gohar Sultan; Asad Shehzad; Abdul Qayum; Syed Ali Anwer Naqvi; Syed Adeeb Ul Hassan Rizvi
Journal:  Urol Ann       Date:  2011-05
View more
  3 in total

1.  Anomalous chin lesion: The many presentations of extraosseous Ewing's sarcoma.

Authors:  Tripthi P Shetty; Titiksha Jain; Padmaraj Hegde
Journal:  Dent Res J (Isfahan)       Date:  2022-06-01

Review 2.  Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature.

Authors:  Shuangping Zhang; Yun Chen; Shiping Guo; Ke-Neng Chen
Journal:  Thorac Cancer       Date:  2021-12-05       Impact factor: 3.500

3.  Neoadjuvant chemotherapy for Ewing's sarcoma family tumors of the uterine cervix: A case report.

Authors:  Masahiko Mori; Kazunori Honda; Hirofumi Tsubouchi; Jun Sakata; Seiichi Kato; Shiro Suzuki
Journal:  Gynecol Oncol Rep       Date:  2021-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.